Marksans Pharma Market Cap

Marksans Pharma has a market cap or net worth of 107.98 billion as of May 15, 2025. Its market cap has increased by 41.70% in one year.

Market Cap

107.98B

Enterprise Value

103.48B

Revenue

24.74B

Ranking

n/a

PE Ratio

29.30

Stock Price

239.61

Market Cap Chart

Since December 13, 2006, Marksans Pharma's market cap has increased from 36.52B to 107.98B, an increase of 195.70%. That is a compound annual growth rate of 6.06%.

Market Cap History

Date	Market Cap	% Change
May 14, 2025	107.98B	-19.68%
Dec 31, 2024	134.43B	84.14%
Dec 29, 2023	73.00B	210.96%
Dec 30, 2022	23.48B	-4.66%
Dec 31, 2021	24.63B	-0.80%
Dec 31, 2020	24.82B	263.17%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Sun Pharmaceutical Industries	4,098.54B
Divi's Laboratories	1,650.02B
Cipla	1,207.26B
Mankind Pharma	1,053.97B
Apollo Hospitals Enterprise	994.49B
Zydus Lifesciences	909.13B
Aurobindo Pharma	708.58B
Alkem Laboratories	613.01B

Market Cap Rankings